A multicenter, randomized, double-blind, placebo-controlled, flexible-dose study to assess the safety and efficacy of topiramate in the treatment of moderate to severe binge-eating disorder associated with obesity.

Trial Profile

A multicenter, randomized, double-blind, placebo-controlled, flexible-dose study to assess the safety and efficacy of topiramate in the treatment of moderate to severe binge-eating disorder associated with obesity.

Completed
Phase of Trial: Phase II/III

Latest Information Update: 03 May 2010

At a glance

  • Drugs Topiramate (Primary)
  • Indications Binge-Eating Disorder; Obesity
  • Focus Therapeutic Use
  • Sponsors Janssen Research & Development
  • Most Recent Events

    • 05 May 2009 Actual number of patients added as 407.
    • 01 May 2007 Status changed from in progress to completed.
    • 04 Dec 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top